Literature DB >> 16187186

Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis.

Kwang Hyuck Lee1, Ji Kon Ryu, Won Jae Yoon, Jun Kyu Lee, Yong-Tae Kim, Yong Bum Yoon.   

Abstract

Several genetic mutations have been reported to increase susceptibility to chronic pancreatitis. However, their roles in alcoholic chronic pancreatitis are controversial. We investigated the prevalence of SPINK1 N34S and new CFTR Q1352H mutations in alcoholic chronic pancreatitis in Korea. Forty-three patients with alcoholic chronic pancreatitis were enrolled and 35 healthy individuals served as controls. The SPINK1 N34S mutation was detected by the PCR-RFLP technique. The CFTR Q1352H mutation was examined with PCR direct sequencing. Mean age of chronic pancreatitis and control groups was 53.2 and 51.3 years, respectively. A SPINK1 N34S was detected as a heterozygote in one (2.4%) patient with alcoholic chronic pancreatitis and a heterozygote CFTR Q1352H was detected in one other patient. In the control population, neither SPINK1 nor CFTR mutation was detected. This study shows that SPINK1 N34S and CFTR Q1352H mutations are uncommon and do not play an important role in chronic alcoholic pancreatitis in Korea.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187186     DOI: 10.1007/s10620-005-2950-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis.

Authors:  H Witt; W Luck; H C Hennies; M Classen; A Kage; U Lass; O Landt; M Becker
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

3.  Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.

Authors:  Niels Teich; Nadine Bauer; Joachim Mössner; Volker Keim
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

4.  Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis.

Authors:  J P H Drenth; R te Morsche; J B M J Jansen
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

5.  Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.

Authors:  J A Cohn; K J Friedman; P G Noone; M R Knowles; L M Silverman; P S Jowell
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

Review 6.  Cystic fibrosis: genotypic and phenotypic variations.

Authors:  J Zielenski; L C Tsui
Journal:  Annu Rev Genet       Date:  1995       Impact factor: 16.830

7.  Multicenter survey of the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreaitis and alcohol, protein and lipid consumption.

Authors:  J P Durbec; H Sarles
Journal:  Digestion       Date:  1978       Impact factor: 3.216

8.  Cystic fibrosis genotypes and alcoholic pancreatitis.

Authors:  I D Norton; M V Apte; H Dixson; R J Trent; P S Haber; R C Pirola; J S Wilson
Journal:  J Gastroenterol Hepatol       Date:  1998-05       Impact factor: 4.029

9.  [Cationic trypsinogen gene mutation in patients with chronic idiopathic pancreatitis].

Authors:  Woo Jin Lee; Kyung-Ah Kim; June Sung Lee; Young Bin Jeon; Ji Bong Jeong; Ji Kon Ryu; Yong-Tae Kim; Yong Bum Yoon; Chung Yong Kim
Journal:  Korean J Gastroenterol       Date:  2004-01

10.  Limited contribution of the SPINK1 N34S mutation to the risk and severity of alcoholic chronic pancreatitis: a report from the United States.

Authors:  Alexander Schneider; Roland H Pfützer; M Michael Barmada; Adam Slivka; John Martin; David C Whitcomb
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

View more
  7 in total

Review 1.  Genetic risk factors for pancreatic disorders.

Authors:  David C Whitcomb
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

2.  Pancreatic secretory trypsin inhibitor: More than a trypsin inhibitor.

Authors:  Gai-Ping Wang; Cun-Shuan Xu
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

3.  Association between cystic fibrosis transmembrane conductance regulator gene mutations and susceptibility for childhood asthma in Korea.

Authors:  Kyung Won Kim; Ji Hyun Lee; Min Goo Lee; Kyung Hwan Kim; Myung Hyun Sohn; Kyu-Earn Kim
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

4.  Polymorphisms of the MCP-1 and HSP70-2 genes in Korean patients with alcoholic chronic pancreatitis.

Authors:  Sang Hyub Lee; Ji Kon Ryu; Ji Bong Jeong; Kyeung-Yeup Lee; Sang Myung Woo; Joo Kyung Park; Ji Won Yoo; Yong-Tae Kim; Yong Bum Yoon
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

5.  The prevalence of cationic trypsinogen (PRSS1) and serine protease inhibitor, Kazal type 1 (SPINK1) gene mutations in Polish patients with alcoholic and idiopathic chronic pancreatitis.

Authors:  Anita Gasiorowska; Renata Talar-Wojnarowska; Leszek Czupryniak; Beata Smolarz; Hanna Romanowicz-Makowska; Andrzej Kulig; Ewa Malecka-Panas
Journal:  Dig Dis Sci       Date:  2010-07-30       Impact factor: 3.199

Review 6.  Genetic risk for alcoholic chronic pancreatitis.

Authors:  Marianges Zadrozny Gouvêa da Costa; Dulce Reis Guarita; Suzane Kioko Ono-Nita; Denise Cerqueira Paranaguá-Vezozzo; Guilherme Eduardo Gonçalves Felga; Martha Regina Arcon Pedroso; Marcelo Moreira Tavares de Souza; Paulo Dominguez Nasser; Camila da Silva Ferreira; Flair José Carrilho
Journal:  Int J Environ Res Public Health       Date:  2011-06-30       Impact factor: 3.390

7.  Pathways to injury in chronic pancreatitis: decoding the role of the high-risk SPINK1 N34S haplotype using meta-analysis.

Authors:  Elie Aoun; Chung-Chou H Chang; Julia B Greer; Georgios I Papachristou; M Michael Barmada; David C Whitcomb
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.